Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Stressgen Cuts Staff, Saving Resources For HPV Vaccine

April 29, 2005

By Jennifer Boggs

Penwest's Beta-Blocker PW2101 Subject Of Prism Marketing Deal

April 28, 2005

By Jennifer Boggs

Penwest's Beta-Blocker PW2101 Subject Of Prism Marketing Deal

April 28, 2005

By Jennifer Boggs

OncoGenex In-Licenses Hsp27 Inhibitors For Isis Collaboration

April 27, 2005

By Jennifer Boggs

OncoGenex In-Licenses Hsp27 Inhibitors For Isis Collaboration

April 27, 2005

By Jennifer Boggs

Prestwick Seeks $75M IPO, Readies Tetrabenazine NDA

April 26, 2005

By Jennifer Boggs

Prestwick Seeks $75M IPO, Readies Tetrabenazine NDA

April 26, 2005

By Jennifer Boggs

Hamilton Pharmaceuticals' First Financing: $11M For CNS Drugs

April 25, 2005

By Jennifer Boggs

Hamilton Pharmaceuticals' First Financing: $11M For CNS Drugs

April 25, 2005

By Jennifer Boggs

Genzyme Beats Consensus, Increases Full-Year Guidance

April 22, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...